Jackson Creek Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Jackson Creek Investment Advisors's BMY Position: Q1 2026 in Review
Jackson Creek Investment Advisors opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 5,730 shares worth $348K. The stake represents 0.1% of the portfolio and ranks #270 among its holdings. This is a return to the name: Jackson Creek Investment Advisors previously reported a position in BMY as recently as Q1 2023.
Jackson Creek Investment Advisors first reported a position in BMY in Q3 2020 and has held it in 3 quarters since. The position peaked at $418K in Q1 2023. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Jackson Creek Investment Advisors held 5,730 shares of Bristol-Myers Squibb worth $348K as of Q1 2026.
- Bristol-Myers Squibb was a new Jackson Creek Investment Advisors position in Q1 2026.
- Bristol-Myers Squibb made up 0.1% of Jackson Creek Investment Advisors's portfolio in Q1 2026, its #270 holding.
- Jackson Creek Investment Advisors first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 3 quarters since.
- Jackson Creek Investment Advisors's Bristol-Myers Squibb position peaked at $418K in Q1 2023.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Jackson Creek Investment Advisors's 13F filing for Q1 2026, filed 5 May 2026.